| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 395 | 2023 | 6882 | 13.600 |
Why?
|
| Psychotic Disorders | 197 | 2023 | 3046 | 9.680 |
Why?
|
| Schizophrenic Psychology | 128 | 2020 | 1678 | 7.450 |
Why?
|
| Diseases in Twins | 56 | 2015 | 449 | 5.760 |
Why?
|
| Genetic Predisposition to Disease | 137 | 2023 | 17446 | 2.990 |
Why?
|
| Schizotypal Personality Disorder | 24 | 2016 | 288 | 2.940 |
Why?
|
| Family | 74 | 2020 | 3147 | 2.780 |
Why?
|
| Bipolar Disorder | 99 | 2019 | 5027 | 2.770 |
Why?
|
| Neuropsychological Tests | 110 | 2021 | 6994 | 2.420 |
Why?
|
| Psychiatric Status Rating Scales | 115 | 2021 | 6036 | 2.300 |
Why?
|
| Genetic Linkage | 39 | 2011 | 2421 | 2.100 |
Why?
|
| Twins, Dizygotic | 34 | 2018 | 236 | 1.980 |
Why?
|
| Twins | 28 | 2016 | 339 | 1.940 |
Why?
|
| Cognition Disorders | 44 | 2023 | 4043 | 1.940 |
Why?
|
| Family Health | 30 | 2021 | 1281 | 1.920 |
Why?
|
| Twins, Monozygotic | 40 | 2018 | 458 | 1.890 |
Why?
|
| Affective Disorders, Psychotic | 17 | 2016 | 191 | 1.740 |
Why?
|
| Endophenotypes | 22 | 2023 | 250 | 1.710 |
Why?
|
| Social Adjustment | 21 | 2020 | 631 | 1.650 |
Why?
|
| Social Environment | 30 | 2011 | 1022 | 1.570 |
Why?
|
| Mental Disorders | 59 | 2021 | 6598 | 1.430 |
Why?
|
| Longitudinal Studies | 111 | 2023 | 13991 | 1.430 |
Why?
|
| Memory, Short-Term | 23 | 2020 | 977 | 1.420 |
Why?
|
| Alcoholism | 44 | 2011 | 1906 | 1.410 |
Why?
|
| Verbal Learning | 13 | 2014 | 468 | 1.280 |
Why?
|
| Adult | 432 | 2023 | 214052 | 1.270 |
Why?
|
| Male | 543 | 2023 | 350115 | 1.240 |
Why?
|
| Humans | 790 | 2023 | 744366 | 1.220 |
Why?
|
| Tobacco Use Disorder | 12 | 2015 | 688 | 1.200 |
Why?
|
| Antisocial Personality Disorder | 19 | 2008 | 228 | 1.180 |
Why?
|
| Mood Disorders | 18 | 2020 | 1106 | 1.160 |
Why?
|
| Adolescent | 239 | 2023 | 85779 | 1.150 |
Why?
|
| Polymorphism, Genetic | 14 | 2010 | 4328 | 1.120 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 21 | 2020 | 1953 | 1.110 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 28 | 2021 | 3658 | 1.090 |
Why?
|
| Depressive Disorder | 50 | 2010 | 3747 | 1.070 |
Why?
|
| Receptors, Dopamine D2 | 6 | 2015 | 475 | 1.060 |
Why?
|
| Conduct Disorder | 6 | 2007 | 241 | 1.040 |
Why?
|
| Substance-Related Disorders | 34 | 2022 | 4257 | 1.030 |
Why?
|
| Polymorphism, Single Nucleotide | 40 | 2023 | 15520 | 1.020 |
Why?
|
| Veterans | 30 | 2014 | 2519 | 1.010 |
Why?
|
| Marijuana Abuse | 12 | 2017 | 403 | 1.010 |
Why?
|
| Brain | 56 | 2023 | 26388 | 0.960 |
Why?
|
| Cerebral Cortex | 27 | 2022 | 5709 | 0.960 |
Why?
|
| Female | 450 | 2023 | 380193 | 0.950 |
Why?
|
| Antipsychotic Agents | 24 | 2022 | 3057 | 0.950 |
Why?
|
| Prefrontal Cortex | 19 | 2016 | 2147 | 0.940 |
Why?
|
| Depressive Disorder, Major | 16 | 2023 | 4639 | 0.930 |
Why?
|
| Chromosome Mapping | 20 | 2009 | 4740 | 0.930 |
Why?
|
| Risk | 71 | 2023 | 9688 | 0.920 |
Why?
|
| Stress Disorders, Post-Traumatic | 19 | 2017 | 4266 | 0.890 |
Why?
|
| Heroin Dependence | 4 | 2008 | 175 | 0.870 |
Why?
|
| Memory Disorders | 12 | 2013 | 1186 | 0.860 |
Why?
|
| Anxiety Disorders | 26 | 2021 | 2690 | 0.850 |
Why?
|
| Intelligence | 11 | 2016 | 920 | 0.840 |
Why?
|
| Thinking | 4 | 2015 | 318 | 0.840 |
Why?
|
| Magnetic Resonance Imaging | 75 | 2023 | 35425 | 0.820 |
Why?
|
| Genetic Markers | 21 | 2017 | 2634 | 0.820 |
Why?
|
| Combat Disorders | 9 | 2014 | 302 | 0.810 |
Why?
|
| Sex Characteristics | 18 | 2020 | 2585 | 0.810 |
Why?
|
| Risk Factors | 143 | 2023 | 72296 | 0.800 |
Why?
|
| Middle Aged | 282 | 2021 | 213390 | 0.800 |
Why?
|
| Genotype | 53 | 2023 | 12952 | 0.800 |
Why?
|
| Case-Control Studies | 73 | 2022 | 21748 | 0.790 |
Why?
|
| Environment | 22 | 2016 | 1123 | 0.760 |
Why?
|
| Attention | 22 | 2016 | 2397 | 0.760 |
Why?
|
| Young Adult | 125 | 2023 | 56429 | 0.750 |
Why?
|
| North America | 25 | 2023 | 1249 | 0.750 |
Why?
|
| Mental Recall | 13 | 2019 | 1206 | 0.740 |
Why?
|
| Twin Studies as Topic | 11 | 2011 | 105 | 0.740 |
Why?
|
| Evoked Potentials, Auditory | 8 | 2022 | 525 | 0.740 |
Why?
|
| Models, Genetic | 31 | 2017 | 3493 | 0.730 |
Why?
|
| Chromosomes, Human, Pair 22 | 6 | 2008 | 351 | 0.730 |
Why?
|
| Hippocampus | 17 | 2022 | 3675 | 0.720 |
Why?
|
| Alleles | 22 | 2022 | 6933 | 0.720 |
Why?
|
| Selenium-Binding Proteins | 3 | 2009 | 14 | 0.710 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 12262 | 0.700 |
Why?
|
| Taiwan | 22 | 2019 | 496 | 0.690 |
Why?
|
| Systems Analysis | 1 | 2020 | 172 | 0.690 |
Why?
|
| Personality Assessment | 9 | 2010 | 647 | 0.680 |
Why?
|
| Brain Mapping | 32 | 2016 | 6670 | 0.680 |
Why?
|
| Smoking | 15 | 2015 | 8987 | 0.670 |
Why?
|
| Phenotype | 59 | 2023 | 16367 | 0.670 |
Why?
|
| Disease Progression | 33 | 2022 | 13286 | 0.670 |
Why?
|
| Age of Onset | 24 | 2019 | 3270 | 0.660 |
Why?
|
| Amphetamine-Related Disorders | 3 | 2010 | 67 | 0.660 |
Why?
|
| Vietnam Conflict | 11 | 2014 | 99 | 0.650 |
Why?
|
| Comorbidity | 43 | 2018 | 10388 | 0.610 |
Why?
|
| Risperidone | 3 | 2012 | 383 | 0.610 |
Why?
|
| Thalamus | 6 | 2016 | 1023 | 0.610 |
Why?
|
| Gene Expression Profiling | 16 | 2023 | 9445 | 0.610 |
Why?
|
| Panic Disorder | 6 | 2011 | 616 | 0.610 |
Why?
|
| Spirituality | 3 | 2008 | 405 | 0.610 |
Why?
|
| Nerve Tissue Proteins | 4 | 2019 | 4463 | 0.580 |
Why?
|
| Child Behavior Disorders | 6 | 2010 | 807 | 0.570 |
Why?
|
| Gene Frequency | 20 | 2015 | 3587 | 0.570 |
Why?
|
| Gambling | 4 | 2001 | 250 | 0.570 |
Why?
|
| Social Perception | 5 | 2018 | 425 | 0.570 |
Why?
|
| Sex Factors | 52 | 2020 | 10400 | 0.560 |
Why?
|
| Lod Score | 14 | 2013 | 614 | 0.560 |
Why?
|
| Blood Cells | 2 | 2011 | 309 | 0.560 |
Why?
|
| Gene Expression | 13 | 2016 | 7798 | 0.530 |
Why?
|
| Multicenter Studies as Topic | 9 | 2020 | 1677 | 0.530 |
Why?
|
| China | 14 | 2020 | 2245 | 0.530 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2007 | 245 | 0.520 |
Why?
|
| Interview, Psychological | 14 | 2017 | 812 | 0.520 |
Why?
|
| Schizophrenia, Paranoid | 17 | 2006 | 104 | 0.520 |
Why?
|
| Pedigree | 29 | 2021 | 4642 | 0.520 |
Why?
|
| Bullying | 6 | 2022 | 210 | 0.510 |
Why?
|
| Military Personnel | 9 | 2015 | 1133 | 0.510 |
Why?
|
| Temporal Lobe | 9 | 2015 | 1670 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2011 | 287 | 0.510 |
Why?
|
| Hydrocortisone | 7 | 2020 | 1826 | 0.500 |
Why?
|
| Acoustic Stimulation | 13 | 2022 | 1216 | 0.490 |
Why?
|
| Functional Laterality | 12 | 2015 | 2290 | 0.490 |
Why?
|
| Models, Psychological | 13 | 2019 | 811 | 0.480 |
Why?
|
| Auditory Perception | 6 | 2019 | 569 | 0.480 |
Why?
|
| Genetic Heterogeneity | 4 | 2008 | 733 | 0.480 |
Why?
|
| Registries | 33 | 2010 | 8091 | 0.480 |
Why?
|
| Birth Injuries | 3 | 2000 | 148 | 0.480 |
Why?
|
| Frontal Lobe | 11 | 2011 | 1406 | 0.480 |
Why?
|
| Haplotypes | 10 | 2016 | 2779 | 0.470 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 240 | 0.470 |
Why?
|
| Child | 100 | 2023 | 77709 | 0.470 |
Why?
|
| Siblings | 14 | 2020 | 854 | 0.470 |
Why?
|
| Depression | 22 | 2020 | 7759 | 0.470 |
Why?
|
| Genetic Association Studies | 11 | 2021 | 2703 | 0.460 |
Why?
|
| Linkage Disequilibrium | 12 | 2013 | 1997 | 0.460 |
Why?
|
| Child of Impaired Parents | 8 | 2013 | 455 | 0.450 |
Why?
|
| Delusions | 14 | 2020 | 300 | 0.450 |
Why?
|
| Odds Ratio | 28 | 2018 | 9849 | 0.450 |
Why?
|
| Stress, Psychological | 12 | 2021 | 4245 | 0.440 |
Why?
|
| Nuclear Family | 11 | 2014 | 318 | 0.430 |
Why?
|
| Amygdala | 6 | 2016 | 1315 | 0.420 |
Why?
|
| Prevalence | 31 | 2017 | 15221 | 0.420 |
Why?
|
| Verbal Behavior | 4 | 2008 | 339 | 0.420 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2011 | 604 | 0.420 |
Why?
|
| Adoption | 8 | 2002 | 97 | 0.410 |
Why?
|
| Electroencephalography | 15 | 2022 | 6151 | 0.410 |
Why?
|
| Hallucinations | 12 | 2017 | 360 | 0.410 |
Why?
|
| Vietnam | 11 | 2011 | 408 | 0.410 |
Why?
|
| Marijuana Smoking | 3 | 2015 | 253 | 0.400 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2012 | 3921 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 15 | 6 | 2004 | 373 | 0.400 |
Why?
|
| Receptors, Opioid, mu | 2 | 2015 | 182 | 0.390 |
Why?
|
| Event-Related Potentials, P300 | 3 | 2019 | 150 | 0.390 |
Why?
|
| Age Factors | 45 | 2023 | 18373 | 0.390 |
Why?
|
| Methamphetamine | 2 | 2010 | 154 | 0.390 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2020 | 703 | 0.390 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.390 |
Why?
|
| Neuroleptic Malignant Syndrome | 2 | 2007 | 71 | 0.390 |
Why?
|
| Cognition | 19 | 2023 | 6770 | 0.380 |
Why?
|
| Emotions | 9 | 2019 | 2659 | 0.380 |
Why?
|
| Psychotropic Drugs | 7 | 2013 | 894 | 0.380 |
Why?
|
| Personality Inventory | 8 | 2012 | 1030 | 0.370 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 2 | 1 | 2009 | 7 | 0.360 |
Why?
|
| Personality Disorders | 11 | 2006 | 713 | 0.360 |
Why?
|
| Suicide | 12 | 2007 | 1474 | 0.360 |
Why?
|
| Alternative Splicing | 3 | 2015 | 1117 | 0.360 |
Why?
|
| Pregnancy Complications | 8 | 2014 | 2861 | 0.360 |
Why?
|
| Leukocytes | 4 | 2017 | 2045 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2019 | 2408 | 0.350 |
Why?
|
| Genetic Variation | 6 | 2017 | 6542 | 0.350 |
Why?
|
| Chromosomes, Human | 4 | 2008 | 457 | 0.350 |
Why?
|
| Affective Symptoms | 12 | 2011 | 407 | 0.350 |
Why?
|
| Cohort Studies | 47 | 2022 | 40559 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 22 | 2019 | 8949 | 0.350 |
Why?
|
| CLOCK Proteins | 1 | 2009 | 88 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2006 | 535 | 0.340 |
Why?
|
| Transients and Migrants | 2 | 2022 | 155 | 0.340 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 1031 | 0.340 |
Why?
|
| Follow-Up Studies | 71 | 2021 | 39052 | 0.340 |
Why?
|
| Psychometrics | 21 | 2015 | 3003 | 0.330 |
Why?
|
| Parahippocampal Gyrus | 2 | 2014 | 116 | 0.330 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2008 | 89 | 0.320 |
Why?
|
| Organ Size | 12 | 2015 | 2251 | 0.320 |
Why?
|
| D-Amino-Acid Oxidase | 3 | 2016 | 27 | 0.320 |
Why?
|
| Theory of Mind | 3 | 2018 | 86 | 0.320 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2007 | 33 | 0.320 |
Why?
|
| Reproducibility of Results | 30 | 2021 | 19905 | 0.320 |
Why?
|
| Genomics | 12 | 2023 | 5717 | 0.320 |
Why?
|
| Minisatellite Repeats | 3 | 2005 | 165 | 0.310 |
Why?
|
| Reference Values | 16 | 2016 | 4982 | 0.310 |
Why?
|
| National Institute of Mental Health (U.S.) | 3 | 2005 | 107 | 0.310 |
Why?
|
| Memory | 12 | 2020 | 2174 | 0.310 |
Why?
|
| Analysis of Variance | 20 | 2017 | 6366 | 0.300 |
Why?
|
| Limbic System | 5 | 2019 | 426 | 0.300 |
Why?
|
| Genes, erbB | 1 | 2007 | 5 | 0.300 |
Why?
|
| Morbidity | 5 | 2020 | 1768 | 0.300 |
Why?
|
| Multifactorial Inheritance | 8 | 2023 | 1195 | 0.300 |
Why?
|
| Psychoses, Substance-Induced | 6 | 2015 | 96 | 0.300 |
Why?
|
| Social Values | 1 | 2008 | 224 | 0.300 |
Why?
|
| Mothers | 5 | 2019 | 2165 | 0.300 |
Why?
|
| Psychomotor Disorders | 2 | 2015 | 152 | 0.300 |
Why?
|
| Severity of Illness Index | 25 | 2019 | 15535 | 0.300 |
Why?
|
| Schizophrenic Language | 3 | 2006 | 69 | 0.290 |
Why?
|
| Social Behavior Disorders | 3 | 2017 | 97 | 0.290 |
Why?
|
| Ganglionic Stimulants | 2 | 2005 | 19 | 0.290 |
Why?
|
| Factor Analysis, Statistical | 9 | 2015 | 977 | 0.290 |
Why?
|
| Life Change Events | 8 | 2017 | 938 | 0.280 |
Why?
|
| Religion and Psychology | 1 | 2008 | 171 | 0.280 |
Why?
|
| Computational Biology | 3 | 2017 | 3519 | 0.280 |
Why?
|
| Paternal Age | 3 | 2019 | 84 | 0.280 |
Why?
|
| Auditory Cortex | 2 | 2020 | 346 | 0.280 |
Why?
|
| Hypothalamus | 2 | 2015 | 1063 | 0.280 |
Why?
|
| Apolipoproteins | 1 | 2008 | 317 | 0.270 |
Why?
|
| Predictive Value of Tests | 17 | 2019 | 15078 | 0.270 |
Why?
|
| Cocaine-Related Disorders | 3 | 2005 | 460 | 0.270 |
Why?
|
| Lipoproteins, HDL | 3 | 2013 | 638 | 0.270 |
Why?
|
| Agoraphobia | 2 | 2004 | 179 | 0.270 |
Why?
|
| Terminology as Topic | 8 | 2003 | 1547 | 0.270 |
Why?
|
| Genome, Human | 8 | 2011 | 4420 | 0.270 |
Why?
|
| Neural Inhibition | 3 | 2017 | 602 | 0.270 |
Why?
|
| Pattern Recognition, Visual | 3 | 2011 | 824 | 0.270 |
Why?
|
| DNA Methylation | 4 | 2016 | 4285 | 0.270 |
Why?
|
| Aged | 87 | 2021 | 163288 | 0.260 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 2865 | 0.260 |
Why?
|
| Risk Assessment | 22 | 2022 | 23336 | 0.260 |
Why?
|
| Cerebral Ventricles | 4 | 2017 | 544 | 0.260 |
Why?
|
| Saccades | 3 | 2014 | 246 | 0.250 |
Why?
|
| Genes | 3 | 2012 | 1893 | 0.250 |
Why?
|
| Paranoid Disorders | 7 | 2013 | 60 | 0.250 |
Why?
|
| Personality | 5 | 2012 | 552 | 0.250 |
Why?
|
| Behavioral Symptoms | 2 | 2013 | 175 | 0.250 |
Why?
|
| Perinatology | 1 | 2004 | 57 | 0.250 |
Why?
|
| Evoked Potentials | 3 | 2022 | 1056 | 0.250 |
Why?
|
| Semantics | 4 | 2006 | 585 | 0.250 |
Why?
|
| Intelligence Tests | 8 | 2015 | 505 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2005 | 299 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 6 | 2008 | 2716 | 0.240 |
Why?
|
| Bulimia | 2 | 2003 | 383 | 0.240 |
Why?
|
| Cannabis | 3 | 2022 | 440 | 0.240 |
Why?
|
| Psychiatry | 5 | 2004 | 1695 | 0.240 |
Why?
|
| Human Genome Project | 2 | 2003 | 193 | 0.240 |
Why?
|
| Homosexuality, Male | 2 | 2004 | 1240 | 0.240 |
Why?
|
| Alcohol-Related Disorders | 2 | 2015 | 234 | 0.240 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2004 | 63 | 0.240 |
Why?
|
| Pituitary-Adrenal System | 2 | 2020 | 553 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 6 | 7 | 2009 | 380 | 0.240 |
Why?
|
| Nicotine | 3 | 2005 | 681 | 0.240 |
Why?
|
| Social Participation | 2 | 2023 | 173 | 0.240 |
Why?
|
| Obsessive-Compulsive Disorder | 6 | 2018 | 1444 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 2008 | 437 | 0.240 |
Why?
|
| Wechsler Scales | 6 | 2016 | 260 | 0.230 |
Why?
|
| Cholinergic Antagonists | 2 | 2023 | 165 | 0.230 |
Why?
|
| MicroRNAs | 2 | 2017 | 3751 | 0.230 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3771 | 0.230 |
Why?
|
| Receptors, Nicotinic | 3 | 2004 | 497 | 0.230 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2003 | 49 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2005 | 460 | 0.230 |
Why?
|
| Disease Susceptibility | 9 | 2020 | 1782 | 0.230 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3646 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2019 | 245 | 0.230 |
Why?
|
| Statistics, Nonparametric | 8 | 2017 | 2887 | 0.230 |
Why?
|
| Phonetics | 3 | 2006 | 206 | 0.230 |
Why?
|
| Early Diagnosis | 6 | 2016 | 1184 | 0.230 |
Why?
|
| Genetic Counseling | 4 | 2001 | 600 | 0.230 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2005 | 266 | 0.230 |
Why?
|
| Coitus | 1 | 2004 | 133 | 0.230 |
Why?
|
| Trinucleotide Repeats | 2 | 2005 | 261 | 0.230 |
Why?
|
| United States | 47 | 2021 | 69872 | 0.230 |
Why?
|
| Genetics, Medical | 4 | 2013 | 338 | 0.230 |
Why?
|
| Inflammation | 3 | 2020 | 10637 | 0.230 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1793 | 0.220 |
Why?
|
| Discrimination Learning | 2 | 1997 | 280 | 0.220 |
Why?
|
| Confidence Intervals | 9 | 2010 | 2971 | 0.220 |
Why?
|
| Resilience, Psychological | 3 | 2023 | 677 | 0.220 |
Why?
|
| Developmental Disabilities | 4 | 2021 | 1456 | 0.220 |
Why?
|
| Potassium Channels | 2 | 2019 | 563 | 0.220 |
Why?
|
| Executive Function | 5 | 2017 | 1364 | 0.220 |
Why?
|
| Health Status | 3 | 2007 | 4034 | 0.220 |
Why?
|
| Smell | 2 | 1997 | 244 | 0.220 |
Why?
|
| Self Concept | 6 | 2016 | 1025 | 0.220 |
Why?
|
| Psychological Tests | 5 | 2016 | 651 | 0.210 |
Why?
|
| Enzymes | 1 | 2004 | 266 | 0.210 |
Why?
|
| Concept Formation | 3 | 1998 | 158 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 4554 | 0.210 |
Why?
|
| Genetic Research | 3 | 2006 | 174 | 0.210 |
Why?
|
| Role | 2 | 2014 | 175 | 0.210 |
Why?
|
| Cluster Analysis | 5 | 2012 | 2715 | 0.210 |
Why?
|
| Psychomotor Performance | 9 | 2014 | 1901 | 0.210 |
Why?
|
| Interpersonal Relations | 5 | 2015 | 1425 | 0.210 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2003 | 798 | 0.210 |
Why?
|
| Point Mutation | 2 | 2005 | 1624 | 0.210 |
Why?
|
| Personal Satisfaction | 3 | 2012 | 643 | 0.200 |
Why?
|
| Statistics as Topic | 11 | 2015 | 2373 | 0.200 |
Why?
|
| Auditory Perceptual Disorders | 3 | 2017 | 36 | 0.200 |
Why?
|
| Fetal Diseases | 2 | 2014 | 903 | 0.200 |
Why?
|
| Alcohol Drinking | 7 | 2015 | 3966 | 0.200 |
Why?
|
| Volition | 2 | 1999 | 63 | 0.200 |
Why?
|
| Pregnancy | 26 | 2019 | 29144 | 0.200 |
Why?
|
| Obstetric Labor Complications | 4 | 2001 | 238 | 0.200 |
Why?
|
| Choroid Plexus | 1 | 2023 | 231 | 0.190 |
Why?
|
| Phobic Disorders | 2 | 2006 | 439 | 0.190 |
Why?
|
| Anxiety | 9 | 2022 | 4293 | 0.190 |
Why?
|
| Manuals as Topic | 9 | 1988 | 98 | 0.190 |
Why?
|
| Wounds and Injuries | 2 | 2005 | 2400 | 0.190 |
Why?
|
| Dominance, Cerebral | 5 | 2006 | 635 | 0.190 |
Why?
|
| Logistic Models | 18 | 2017 | 13409 | 0.190 |
Why?
|
| Child Abuse | 2 | 2020 | 1030 | 0.190 |
Why?
|
| Fetal Hypoxia | 2 | 2000 | 29 | 0.190 |
Why?
|
| Diagnosis, Differential | 25 | 2002 | 12961 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 850 | 0.190 |
Why?
|
| Self Mutilation | 1 | 2000 | 58 | 0.190 |
Why?
|
| Haloperidol | 5 | 1997 | 397 | 0.180 |
Why?
|
| Microsatellite Repeats | 6 | 2010 | 802 | 0.180 |
Why?
|
| Saliva | 4 | 2020 | 809 | 0.180 |
Why?
|
| Glycolysis | 1 | 2004 | 829 | 0.180 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2012 | 544 | 0.180 |
Why?
|
| Genome | 2 | 2008 | 1807 | 0.180 |
Why?
|
| Syndrome | 10 | 2019 | 3252 | 0.180 |
Why?
|
| Causality | 5 | 2015 | 1275 | 0.180 |
Why?
|
| Sexual Partners | 1 | 2004 | 729 | 0.180 |
Why?
|
| Probability | 9 | 2023 | 2506 | 0.170 |
Why?
|
| Nonverbal Communication | 1 | 1999 | 63 | 0.170 |
Why?
|
| Serine Endopeptidases | 1 | 2005 | 1073 | 0.170 |
Why?
|
| Mental Health | 5 | 2012 | 3010 | 0.170 |
Why?
|
| Cross-Sectional Studies | 17 | 2022 | 25039 | 0.170 |
Why?
|
| Pilot Projects | 13 | 2014 | 8319 | 0.170 |
Why?
|
| Genetics | 1 | 2000 | 112 | 0.170 |
Why?
|
| Family Characteristics | 6 | 2010 | 1000 | 0.170 |
Why?
|
| Iowa | 18 | 1996 | 101 | 0.170 |
Why?
|
| Reaction Time | 7 | 2019 | 2098 | 0.170 |
Why?
|
| Chi-Square Distribution | 7 | 2013 | 3508 | 0.170 |
Why?
|
| Remission Induction | 2 | 2022 | 2385 | 0.170 |
Why?
|
| Sulfotransferases | 1 | 2019 | 151 | 0.160 |
Why?
|
| Minority Groups | 2 | 2023 | 1221 | 0.160 |
Why?
|
| Genetic Testing | 4 | 2016 | 3444 | 0.160 |
Why?
|
| Clozapine | 3 | 2007 | 498 | 0.160 |
Why?
|
| Nortriptyline | 4 | 1986 | 81 | 0.160 |
Why?
|
| Social Behavior | 4 | 2017 | 1127 | 0.160 |
Why?
|
| Expressed Emotion | 2 | 2014 | 92 | 0.160 |
Why?
|
| Calcineurin | 2 | 2011 | 226 | 0.160 |
Why?
|
| Mental Processes | 2 | 2007 | 249 | 0.160 |
Why?
|
| Exons | 4 | 2019 | 2439 | 0.160 |
Why?
|
| Prognosis | 25 | 2022 | 29060 | 0.160 |
Why?
|
| Principal Component Analysis | 4 | 2018 | 940 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2019 | 2026 | 0.160 |
Why?
|
| Schizophrenia, Disorganized | 10 | 2006 | 11 | 0.160 |
Why?
|
| Culture | 2 | 2015 | 633 | 0.160 |
Why?
|
| Models, Statistical | 11 | 2016 | 5101 | 0.150 |
Why?
|
| Political Systems | 1 | 1997 | 23 | 0.150 |
Why?
|
| War Crimes | 1 | 1997 | 22 | 0.150 |
Why?
|
| Suicide, Attempted | 8 | 2023 | 1218 | 0.150 |
Why?
|
| Epidemiology | 1 | 2000 | 287 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 3 | 2006 | 5867 | 0.150 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2018 | 957 | 0.150 |
Why?
|
| Gyrus Cinguli | 3 | 2018 | 1091 | 0.150 |
Why?
|
| Prospective Studies | 24 | 2023 | 53290 | 0.150 |
Why?
|
| Nerve Net | 6 | 2021 | 2175 | 0.150 |
Why?
|
| Association Learning | 1 | 2019 | 224 | 0.150 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 399 | 0.150 |
Why?
|
| Child Psychiatry | 1 | 2000 | 220 | 0.150 |
Why?
|
| Brain Chemistry | 1 | 2001 | 982 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2008 | 374 | 0.150 |
Why?
|
| Immune System Phenomena | 1 | 2016 | 16 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 2 | 2003 | 1148 | 0.150 |
Why?
|
| Psychophysiologic Disorders | 1 | 1999 | 228 | 0.150 |
Why?
|
| Educational Status | 6 | 2015 | 2540 | 0.150 |
Why?
|
| Sibling Relations | 1 | 1996 | 45 | 0.150 |
Why?
|
| Professional Misconduct | 1 | 1997 | 73 | 0.150 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2018 | 2305 | 0.140 |
Why?
|
| Community Mental Health Centers | 1 | 1997 | 102 | 0.140 |
Why?
|
| Vocabulary | 1 | 1997 | 169 | 0.140 |
Why?
|
| Human Experimentation | 1 | 1997 | 127 | 0.140 |
Why?
|
| Multivariate Analysis | 11 | 2017 | 12244 | 0.140 |
Why?
|
| Sex Chromosome Aberrations | 5 | 1990 | 114 | 0.140 |
Why?
|
| Paroxetine | 1 | 1997 | 182 | 0.140 |
Why?
|
| Socioeconomic Factors | 11 | 2014 | 7785 | 0.140 |
Why?
|
| Cerebellum | 2 | 2015 | 1488 | 0.140 |
Why?
|
| Corpus Callosum | 2 | 2021 | 737 | 0.140 |
Why?
|
| Olfaction Disorders | 1 | 2018 | 222 | 0.140 |
Why?
|
| Space Perception | 2 | 2011 | 475 | 0.140 |
Why?
|
| Oxygen | 7 | 2014 | 4189 | 0.140 |
Why?
|
| Catatonia | 5 | 2013 | 158 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2019 | 1730 | 0.140 |
Why?
|
| Virus Diseases | 3 | 2015 | 711 | 0.140 |
Why?
|
| Attitude to Health | 2 | 2004 | 2052 | 0.140 |
Why?
|
| Tourette Syndrome | 2 | 1996 | 379 | 0.140 |
Why?
|
| Ethics, Medical | 2 | 2001 | 792 | 0.140 |
Why?
|
| Task Performance and Analysis | 5 | 2012 | 780 | 0.140 |
Why?
|
| Inheritance Patterns | 4 | 2016 | 340 | 0.130 |
Why?
|
| Anorexia Nervosa | 2 | 2008 | 1286 | 0.130 |
Why?
|
| Histone Code | 1 | 2016 | 163 | 0.130 |
Why?
|
| Child, Preschool | 23 | 2021 | 41005 | 0.130 |
Why?
|
| Research Design | 15 | 2007 | 5984 | 0.130 |
Why?
|
| Genetic Loci | 4 | 2023 | 2575 | 0.130 |
Why?
|
| Language Disorders | 2 | 2006 | 141 | 0.130 |
Why?
|
| Receptors, Dopamine D4 | 2 | 2008 | 171 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 1 | 2000 | 850 | 0.130 |
Why?
|
| Bulimia Nervosa | 2 | 2008 | 177 | 0.130 |
Why?
|
| Aptitude | 1 | 1995 | 45 | 0.130 |
Why?
|
| Ubiquitin | 2 | 2010 | 851 | 0.130 |
Why?
|
| Patient Dropouts | 1 | 2017 | 420 | 0.130 |
Why?
|
| Facial Expression | 5 | 2018 | 508 | 0.130 |
Why?
|
| Parents | 7 | 2020 | 3405 | 0.130 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 231 | 0.130 |
Why?
|
| Regression Analysis | 9 | 2007 | 6459 | 0.130 |
Why?
|
| DNA Mutational Analysis | 5 | 2016 | 4185 | 0.130 |
Why?
|
| Genes, Recessive | 3 | 2015 | 641 | 0.120 |
Why?
|
| Epidemiologic Methods | 5 | 2000 | 1364 | 0.120 |
Why?
|
| Bacterial Infections | 2 | 2019 | 1401 | 0.120 |
Why?
|
| Epidemiologic Research Design | 2 | 2015 | 367 | 0.120 |
Why?
|
| Behavior, Addictive | 1 | 2000 | 462 | 0.120 |
Why?
|
| Cues | 1 | 1999 | 875 | 0.120 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 12073 | 0.120 |
Why?
|
| Habituation, Psychophysiologic | 2 | 2013 | 154 | 0.120 |
Why?
|
| Travel | 1 | 2020 | 788 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 3617 | 0.120 |
Why?
|
| Human Rights | 1 | 1997 | 307 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2000 | 582 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2006 | 462 | 0.120 |
Why?
|
| Mutation | 8 | 2022 | 29786 | 0.120 |
Why?
|
| Electroconvulsive Therapy | 6 | 1982 | 477 | 0.120 |
Why?
|
| Adaptation, Psychological | 4 | 2015 | 2575 | 0.120 |
Why?
|
| Sensory Gating | 1 | 2014 | 47 | 0.120 |
Why?
|
| New England | 5 | 2019 | 1022 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 13 | 3 | 2006 | 197 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2015 | 4042 | 0.120 |
Why?
|
| Quality of Life | 8 | 2015 | 12802 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2010 | 1335 | 0.120 |
Why?
|
| Apolipoproteins E | 3 | 2022 | 1438 | 0.120 |
Why?
|
| Genetics, Behavioral | 2 | 2012 | 53 | 0.110 |
Why?
|
| Medical Record Linkage | 2 | 2001 | 284 | 0.110 |
Why?
|
| Logic | 1 | 2013 | 39 | 0.110 |
Why?
|
| Lithium | 6 | 1981 | 601 | 0.110 |
Why?
|
| Mental Competency | 1 | 2014 | 176 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 1061 | 0.110 |
Why?
|
| Blood Proteins | 1 | 2018 | 1124 | 0.110 |
Why?
|
| Apolipoprotein E4 | 2 | 2022 | 668 | 0.110 |
Why?
|
| Austria | 2 | 2003 | 202 | 0.110 |
Why?
|
| Sex Differentiation | 1 | 2013 | 73 | 0.110 |
Why?
|
| Dyslipidemias | 2 | 2018 | 849 | 0.110 |
Why?
|
| Nervous System Diseases | 2 | 2002 | 1622 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2018 | 5023 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2005 | 369 | 0.110 |
Why?
|
| Aging | 9 | 2014 | 8664 | 0.110 |
Why?
|
| Maternal Behavior | 1 | 1995 | 311 | 0.110 |
Why?
|
| Neural Pathways | 5 | 2019 | 2974 | 0.110 |
Why?
|
| Puberty | 1 | 2016 | 490 | 0.110 |
Why?
|
| Pharmacogenetics | 2 | 2007 | 674 | 0.110 |
Why?
|
| Marriage | 8 | 1991 | 339 | 0.110 |
Why?
|
| Autistic Disorder | 3 | 2011 | 1185 | 0.110 |
Why?
|
| Cognitive Reserve | 1 | 2013 | 76 | 0.110 |
Why?
|
| Double-Blind Method | 8 | 2018 | 12025 | 0.110 |
Why?
|
| CpG Islands | 3 | 2006 | 1170 | 0.100 |
Why?
|
| Survival Analysis | 7 | 2017 | 10252 | 0.100 |
Why?
|
| Sampling Studies | 1 | 1993 | 623 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2002 | 133 | 0.100 |
Why?
|
| Linear Models | 7 | 2020 | 5953 | 0.100 |
Why?
|
| Introns | 3 | 2009 | 992 | 0.100 |
Why?
|
| Cooperative Behavior | 3 | 2012 | 1504 | 0.100 |
Why?
|
| Annexin A7 | 1 | 2011 | 3 | 0.100 |
Why?
|
| Perceptual Disorders | 2 | 2017 | 196 | 0.100 |
Why?
|
| Chronic Disease | 10 | 2012 | 9145 | 0.100 |
Why?
|
| Interviews as Topic | 4 | 2010 | 2539 | 0.100 |
Why?
|
| Flushing | 1 | 2011 | 49 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2016 | 3001 | 0.100 |
Why?
|
| Cytokines | 5 | 2018 | 7323 | 0.100 |
Why?
|
| Bayes Theorem | 2 | 2017 | 2307 | 0.100 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2011 | 80 | 0.100 |
Why?
|
| Fibromyalgia | 2 | 2008 | 388 | 0.100 |
Why?
|
| Object Attachment | 1 | 2014 | 313 | 0.100 |
Why?
|
| Retrospective Studies | 24 | 2023 | 77460 | 0.100 |
Why?
|
| Feedback, Psychological | 1 | 2011 | 97 | 0.100 |
Why?
|
| Risk-Taking | 2 | 2015 | 986 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2014 | 751 | 0.100 |
Why?
|
| Patient Selection | 3 | 2020 | 4216 | 0.090 |
Why?
|
| Atrophy | 5 | 2014 | 1584 | 0.090 |
Why?
|
| Remission, Spontaneous | 3 | 2018 | 382 | 0.090 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2005 | 632 | 0.090 |
Why?
|
| Receptor, trkB | 1 | 2011 | 125 | 0.090 |
Why?
|
| Niacin | 1 | 2011 | 116 | 0.090 |
Why?
|
| Time Factors | 15 | 2016 | 40075 | 0.090 |
Why?
|
| Genetics, Population | 3 | 2019 | 934 | 0.090 |
Why?
|
| Testosterone | 2 | 2011 | 2419 | 0.090 |
Why?
|
| Receptors, Notch | 3 | 2005 | 739 | 0.090 |
Why?
|
| Brain Diseases | 4 | 2011 | 1563 | 0.090 |
Why?
|
| Forecasting | 5 | 2000 | 2951 | 0.090 |
Why?
|
| Research | 3 | 2008 | 1999 | 0.090 |
Why?
|
| Self Report | 3 | 2017 | 3553 | 0.090 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1982 | 434 | 0.090 |
Why?
|
| Arrestins | 1 | 2010 | 74 | 0.090 |
Why?
|
| Affect | 5 | 2018 | 1475 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2005 | 1525 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2017 | 3020 | 0.090 |
Why?
|
| Lorazepam | 2 | 1990 | 145 | 0.090 |
Why?
|
| Sample Size | 4 | 2016 | 845 | 0.090 |
Why?
|
| Sex Distribution | 3 | 2006 | 2297 | 0.090 |
Why?
|
| ROC Curve | 4 | 2016 | 3528 | 0.090 |
Why?
|
| Violence | 1 | 2016 | 909 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2009 | 45 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 1999 | 2055 | 0.090 |
Why?
|
| Infant, Newborn | 10 | 2011 | 25628 | 0.090 |
Why?
|
| DNA | 5 | 2007 | 7294 | 0.090 |
Why?
|
| Achievement | 2 | 2006 | 291 | 0.090 |
Why?
|
| Europe | 3 | 2003 | 3338 | 0.090 |
Why?
|
| Rhode Island | 1 | 2010 | 347 | 0.090 |
Why?
|
| Visual Perception | 3 | 2015 | 1420 | 0.090 |
Why?
|
| Personality Tests | 2 | 2000 | 83 | 0.090 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2013 | 260 | 0.090 |
Why?
|
| Demography | 3 | 2006 | 1655 | 0.080 |
Why?
|
| Antidepressive Agents | 4 | 2009 | 2838 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 1344 | 0.080 |
Why?
|
| Likelihood Functions | 3 | 2017 | 1005 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2012 | 615 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 14723 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4751 | 0.080 |
Why?
|
| Receptors, Dopamine | 2 | 2004 | 295 | 0.080 |
Why?
|
| Smoking Cessation | 4 | 2006 | 2071 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 8038 | 0.080 |
Why?
|
| Infant | 12 | 2013 | 35134 | 0.080 |
Why?
|
| Binge-Eating Disorder | 1 | 2010 | 137 | 0.080 |
Why?
|
| Breech Presentation | 1 | 1988 | 44 | 0.080 |
Why?
|
| Arousal | 5 | 2015 | 1164 | 0.080 |
Why?
|
| Parietal Lobe | 3 | 2005 | 838 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2013 | 970 | 0.080 |
Why?
|
| Social Class | 7 | 2005 | 1997 | 0.080 |
Why?
|
| Molecular Motor Proteins | 1 | 2008 | 107 | 0.080 |
Why?
|
| Weight Gain | 1 | 2018 | 2293 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 1998 | 780 | 0.080 |
Why?
|
| Nucleosomes | 1 | 2011 | 494 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 3759 | 0.080 |
Why?
|
| Boston | 5 | 2010 | 9312 | 0.080 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.080 |
Why?
|
| Existentialism | 1 | 2007 | 33 | 0.080 |
Why?
|
| Dagestan | 1 | 2006 | 1 | 0.070 |
Why?
|
| Ambulatory Care | 5 | 2006 | 2708 | 0.070 |
Why?
|
| Overweight | 1 | 2018 | 2371 | 0.070 |
Why?
|
| Monocytes | 1 | 2016 | 2596 | 0.070 |
Why?
|
| RNA, Messenger | 6 | 2013 | 13035 | 0.070 |
Why?
|
| Residence Characteristics | 7 | 2022 | 2050 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 1152 | 0.070 |
Why?
|
| Poverty | 1 | 2019 | 2660 | 0.070 |
Why?
|
| Base Sequence | 3 | 2011 | 12797 | 0.070 |
Why?
|
| Behavior, Animal | 3 | 2011 | 1881 | 0.070 |
Why?
|
| North Carolina | 1 | 2007 | 315 | 0.070 |
Why?
|
| Employment | 6 | 2017 | 1132 | 0.070 |
Why?
|
| Algorithms | 5 | 2017 | 13882 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 414 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 2 | 2008 | 1342 | 0.070 |
Why?
|
| Adolescent Behavior | 1 | 1995 | 1151 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 2 | 2003 | 651 | 0.070 |
Why?
|
| Receptor, Notch2 | 1 | 2006 | 89 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1707 | 0.070 |
Why?
|
| Mortality | 6 | 1996 | 2864 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 1865 | 0.070 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2008 | 214 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2010 | 581 | 0.070 |
Why?
|
| RGS Proteins | 1 | 2006 | 77 | 0.070 |
Why?
|
| Life Style | 3 | 2008 | 3835 | 0.070 |
Why?
|
| Sex Chromatin | 3 | 1975 | 20 | 0.070 |
Why?
|
| Environmental Exposure | 2 | 2003 | 4232 | 0.070 |
Why?
|
| Religion and Medicine | 1 | 2007 | 163 | 0.070 |
Why?
|
| Neurotransmitter Agents | 3 | 2007 | 647 | 0.070 |
Why?
|
| Valine | 1 | 2007 | 413 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 1837 | 0.060 |
Why?
|
| Psychology | 1 | 2007 | 356 | 0.060 |
Why?
|
| Social Security | 1 | 1985 | 101 | 0.060 |
Why?
|
| Fatigue | 1 | 2012 | 1531 | 0.060 |
Why?
|
| RNA | 2 | 2005 | 2749 | 0.060 |
Why?
|
| Phosphofructokinase-1 | 1 | 2004 | 51 | 0.060 |
Why?
|
| Animals | 17 | 2016 | 168768 | 0.060 |
Why?
|
| Methionine | 1 | 2007 | 590 | 0.060 |
Why?
|
| Benzodiazepines | 2 | 2009 | 1101 | 0.060 |
Why?
|
| Drug Design | 2 | 2009 | 1076 | 0.060 |
Why?
|
| Phosphofructokinase-2 | 1 | 2004 | 32 | 0.060 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 875 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2009 | 10943 | 0.060 |
Why?
|
| Lentigo | 2 | 1982 | 37 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2008 | 622 | 0.060 |
Why?
|
| Birth Order | 4 | 1984 | 95 | 0.060 |
Why?
|
| Schizophrenia, Catatonic | 5 | 1985 | 7 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 302 | 0.060 |
Why?
|
| Founder Effect | 1 | 2005 | 189 | 0.060 |
Why?
|
| Public Opinion | 1 | 2008 | 477 | 0.060 |
Why?
|
| Serine | 1 | 2008 | 826 | 0.060 |
Why?
|
| Hypertension | 3 | 2018 | 8479 | 0.060 |
Why?
|
| Russia | 1 | 2005 | 408 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.060 |
Why?
|
| Hexokinase | 1 | 2004 | 124 | 0.060 |
Why?
|
| Anisotropy | 2 | 2018 | 1265 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 645 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7282 | 0.060 |
Why?
|
| Disease Models, Animal | 6 | 2012 | 18034 | 0.060 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2003 | 45 | 0.060 |
Why?
|
| Incidence | 5 | 2015 | 20952 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2441 | 0.060 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 288 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2916 | 0.060 |
Why?
|
| Maternal Deprivation | 1 | 1983 | 48 | 0.060 |
Why?
|
| Colonic Diseases, Functional | 1 | 2003 | 38 | 0.060 |
Why?
|
| Genetic Load | 1 | 2003 | 15 | 0.060 |
Why?
|
| Cysteine | 1 | 2008 | 873 | 0.060 |
Why?
|
| Migraine Disorders | 2 | 2008 | 1620 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3084 | 0.060 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2002 | 30 | 0.060 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 322 | 0.060 |
Why?
|
| Receptors, Serotonin | 1 | 2004 | 201 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2015 | 2962 | 0.050 |
Why?
|
| Dyslexia | 1 | 2005 | 248 | 0.050 |
Why?
|
| Biometry | 1 | 2006 | 558 | 0.050 |
Why?
|
| Hospitalization | 11 | 2002 | 10259 | 0.050 |
Why?
|
| Phencyclidine | 2 | 2007 | 61 | 0.050 |
Why?
|
| Schizoid Personality Disorder | 2 | 1979 | 14 | 0.050 |
Why?
|
| Geography | 1 | 2005 | 669 | 0.050 |
Why?
|
| Psychotherapy | 2 | 2010 | 1642 | 0.050 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2005 | 422 | 0.050 |
Why?
|
| Random Allocation | 2 | 2002 | 2428 | 0.050 |
Why?
|
| Cataplexy | 1 | 2003 | 60 | 0.050 |
Why?
|
| Pyruvate Kinase | 1 | 2004 | 189 | 0.050 |
Why?
|
| Serial Learning | 2 | 2008 | 45 | 0.050 |
Why?
|
| Galvanic Skin Response | 1 | 2004 | 349 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 1170 | 0.050 |
Why?
|
| Recurrence | 6 | 2000 | 8340 | 0.050 |
Why?
|
| Asia, Southeastern | 1 | 2002 | 111 | 0.050 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 445 | 0.050 |
Why?
|
| DNA Primers | 1 | 2007 | 2891 | 0.050 |
Why?
|
| Models, Neurological | 2 | 2002 | 1775 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 655 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 4 | 2013 | 719 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 1983 | 202 | 0.050 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1982 | 158 | 0.050 |
Why?
|
| Ureteral Calculi | 1 | 1983 | 110 | 0.050 |
Why?
|
| Neuronal Plasticity | 2 | 2021 | 1423 | 0.050 |
Why?
|
| Observer Variation | 2 | 2006 | 2593 | 0.050 |
Why?
|
| Seminal Vesicles | 1 | 1981 | 101 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2002 | 296 | 0.050 |
Why?
|
| Thiazoles | 1 | 2009 | 1483 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 1995 | 980 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2011 | 2504 | 0.050 |
Why?
|
| Eugenics | 2 | 1997 | 15 | 0.050 |
Why?
|
| Neurotic Disorders | 5 | 1984 | 79 | 0.050 |
Why?
|
| Asia | 1 | 2003 | 609 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 2050 | 0.050 |
Why?
|
| Data Collection | 4 | 2006 | 3339 | 0.050 |
Why?
|
| Databases, Factual | 3 | 2008 | 7730 | 0.050 |
Why?
|
| History, 20th Century | 3 | 1997 | 2740 | 0.050 |
Why?
|
| Rest | 2 | 2021 | 901 | 0.050 |
Why?
|
| Fluphenazine | 2 | 1991 | 36 | 0.050 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2001 | 295 | 0.050 |
Why?
|
| Histones | 1 | 2011 | 2598 | 0.050 |
Why?
|
| New Jersey | 4 | 2002 | 290 | 0.050 |
Why?
|
| Brain Damage, Chronic | 2 | 1979 | 265 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 747 | 0.050 |
Why?
|
| Mathematics | 3 | 1995 | 728 | 0.050 |
Why?
|
| Models, Biological | 6 | 2014 | 9584 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 6 | 1985 | 1877 | 0.050 |
Why?
|
| Postmortem Changes | 2 | 2012 | 124 | 0.050 |
Why?
|
| Insurance Claim Reporting | 1 | 2001 | 163 | 0.050 |
Why?
|
| Biological Psychiatry | 1 | 2000 | 25 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 1992 | 2134 | 0.050 |
Why?
|
| Reading | 3 | 2007 | 558 | 0.050 |
Why?
|
| Neuregulins | 1 | 2019 | 35 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 245 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2009 | 1373 | 0.040 |
Why?
|
| Proteome | 2 | 2016 | 1798 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2007 | 1210 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 5749 | 0.040 |
Why?
|
| Speech Perception | 2 | 2014 | 490 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2003 | 435 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 2019 | 0.040 |
Why?
|
| Proportional Hazards Models | 6 | 2021 | 12356 | 0.040 |
Why?
|
| Personality Development | 2 | 1990 | 245 | 0.040 |
Why?
|
| Disability Evaluation | 3 | 2017 | 1828 | 0.040 |
Why?
|
| Clinical Trials as Topic | 3 | 2007 | 7914 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 1985 | 819 | 0.040 |
Why?
|
| Maternal Welfare | 1 | 2000 | 115 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2003 | 596 | 0.040 |
Why?
|
| Acoustics | 1 | 2020 | 240 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 1988 | 1200 | 0.040 |
Why?
|
| Prediabetic State | 2 | 2018 | 499 | 0.040 |
Why?
|
| Japan | 1 | 2003 | 1360 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 438 | 0.040 |
Why?
|
| Medical Records | 2 | 2000 | 1413 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2001 | 247 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 2018 | 98 | 0.040 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 1979 | 92 | 0.040 |
Why?
|
| Signal Detection, Psychological | 1 | 1998 | 85 | 0.040 |
Why?
|
| Connexins | 1 | 2020 | 357 | 0.040 |
Why?
|
| Karyotyping | 4 | 2011 | 1243 | 0.040 |
Why?
|
| Family Therapy | 1 | 2020 | 207 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2021 | 427 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2488 | 0.040 |
Why?
|
| Hospital Records | 2 | 1991 | 95 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 2 | 1997 | 332 | 0.040 |
Why?
|
| Dysthymic Disorder | 1 | 1998 | 74 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1979 | 189 | 0.040 |
Why?
|
| Prehypertension | 1 | 2018 | 61 | 0.040 |
Why?
|
| Juvenile Delinquency | 2 | 1993 | 125 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2018 | 149 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 995 | 0.040 |
Why?
|
| Neurons | 3 | 2012 | 9340 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2000 | 404 | 0.040 |
Why?
|
| Superior Sagittal Sinus | 1 | 2017 | 17 | 0.040 |
Why?
|
| Mice | 9 | 2011 | 81201 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2018 | 195 | 0.040 |
Why?
|
| Codes of Ethics | 1 | 1997 | 62 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1999 | 379 | 0.040 |
Why?
|
| Chromosomes | 3 | 2010 | 596 | 0.040 |
Why?
|
| State Government | 1 | 2000 | 372 | 0.040 |
Why?
|
| Biomedical Research | 2 | 2012 | 3309 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2002 | 575 | 0.040 |
Why?
|
| Contingent Negative Variation | 1 | 2017 | 34 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 281 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 670 | 0.040 |
Why?
|
| Family Relations | 1 | 1999 | 321 | 0.040 |
Why?
|
| Age Distribution | 1 | 2003 | 2902 | 0.040 |
Why?
|
| Observation | 1 | 1999 | 312 | 0.040 |
Why?
|
| Radiography | 4 | 2013 | 7023 | 0.040 |
Why?
|
| National Socialism | 1 | 1997 | 53 | 0.040 |
Why?
|
| Prolactin | 2 | 2002 | 669 | 0.040 |
Why?
|
| Sex Chromosomes | 2 | 2013 | 105 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 18111 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 1981 | 20130 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 896 | 0.040 |
Why?
|
| Computers | 2 | 2015 | 612 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2001 | 1537 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2002 | 1107 | 0.040 |
Why?
|
| Socialization | 1 | 1996 | 87 | 0.040 |
Why?
|
| Neuroimmunomodulation | 1 | 2018 | 157 | 0.040 |
Why?
|
| Choline | 1 | 2018 | 493 | 0.040 |
Why?
|
| Temperament | 1 | 1998 | 283 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4222 | 0.030 |
Why?
|
| Criminal Psychology | 1 | 1995 | 17 | 0.030 |
Why?
|
| Paranoid Personality Disorder | 1 | 1995 | 8 | 0.030 |
Why?
|
| Language Tests | 2 | 2006 | 202 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 570 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5615 | 0.030 |
Why?
|
| Problem Solving | 2 | 2008 | 440 | 0.030 |
Why?
|
| Friends | 1 | 2017 | 154 | 0.030 |
Why?
|
| Diabetes Insipidus | 1 | 1976 | 151 | 0.030 |
Why?
|
| Euphoria | 1 | 1975 | 67 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1980 | 2031 | 0.030 |
Why?
|
| Motivation | 2 | 2001 | 1971 | 0.030 |
Why?
|
| Monoamine Oxidase | 1 | 1996 | 178 | 0.030 |
Why?
|
| Eye Movement Measurements | 1 | 2014 | 35 | 0.030 |
Why?
|
| Paired-Associate Learning | 1 | 1995 | 52 | 0.030 |
Why?
|
| Seasons | 2 | 1992 | 1493 | 0.030 |
Why?
|
| Schools | 1 | 2023 | 1433 | 0.030 |
Why?
|
| Aged, 80 and over | 8 | 2012 | 57776 | 0.030 |
Why?
|
| X Chromosome | 2 | 1990 | 814 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 1975 | 48 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 638 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 2219 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 1058 | 0.030 |
Why?
|
| Telephone | 1 | 1998 | 617 | 0.030 |
Why?
|
| Mass Screening | 3 | 2001 | 5253 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 1981 | 1198 | 0.030 |
Why?
|
| Pleasure | 1 | 2014 | 41 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 209 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2173 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 1246 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2795 | 0.030 |
Why?
|
| Underachievement | 1 | 1993 | 15 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2006 | 504 | 0.030 |
Why?
|
| Skull | 1 | 1978 | 814 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2018 | 12207 | 0.030 |
Why?
|
| Heart Diseases | 2 | 2006 | 2789 | 0.030 |
Why?
|
| Confidentiality | 1 | 1998 | 612 | 0.030 |
Why?
|
| Breast Neoplasms | 4 | 2002 | 20824 | 0.030 |
Why?
|
| Life Tables | 1 | 1994 | 370 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4805 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1081 | 0.030 |
Why?
|
| Dichotic Listening Tests | 1 | 1993 | 22 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 2008 | 652 | 0.030 |
Why?
|
| Hallucinogens | 1 | 1996 | 180 | 0.030 |
Why?
|
| Education, Special | 1 | 1993 | 87 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 767 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2014 | 272 | 0.030 |
Why?
|
| Cephalometry | 1 | 1995 | 382 | 0.030 |
Why?
|
| Intramolecular Transferases | 1 | 2012 | 15 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2190 | 0.030 |
Why?
|
| Anger | 1 | 1975 | 402 | 0.030 |
Why?
|
| Medicaid | 3 | 2001 | 2737 | 0.030 |
Why?
|
| Kinetics | 6 | 1986 | 6476 | 0.030 |
Why?
|
| Prejudice | 1 | 1997 | 570 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 1979 | 748 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 9955 | 0.030 |
Why?
|
| Prostatectomy | 1 | 1981 | 1890 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3203 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1995 | 514 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1980 | 1681 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2010 | 1121 | 0.030 |
Why?
|
| Proteins | 1 | 2007 | 6100 | 0.030 |
Why?
|
| Sex Ratio | 2 | 1987 | 110 | 0.030 |
Why?
|
| Brain Edema | 1 | 2017 | 617 | 0.030 |
Why?
|
| Catecholamines | 1 | 1993 | 387 | 0.030 |
Why?
|
| Maternal Age | 2 | 1983 | 802 | 0.030 |
Why?
|
| Half-Life | 4 | 1986 | 661 | 0.030 |
Why?
|
| Mosaicism | 1 | 1975 | 441 | 0.030 |
Why?
|
| Eye Movements | 1 | 1995 | 507 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1981 | 1856 | 0.030 |
Why?
|
| Confusion | 2 | 2005 | 275 | 0.030 |
Why?
|
| Thioridazine | 1 | 1971 | 33 | 0.030 |
Why?
|
| Metagenome | 1 | 2015 | 418 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 1997 | 6489 | 0.030 |
Why?
|
| Behavior | 2 | 2008 | 561 | 0.030 |
Why?
|
| Orientation | 2 | 2006 | 327 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2002 | 2732 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2016 | 553 | 0.020 |
Why?
|
| DNA Probes | 1 | 2012 | 560 | 0.020 |
Why?
|
| Scalp | 1 | 1974 | 380 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 173 | 0.020 |
Why?
|
| Information Systems | 1 | 1993 | 410 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2001 | 1212 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2012 | 3531 | 0.020 |
Why?
|
| Public Health | 1 | 2004 | 2602 | 0.020 |
Why?
|
| Brain Injuries | 2 | 2001 | 2029 | 0.020 |
Why?
|
| Glucose | 1 | 2003 | 4398 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2002 | 1644 | 0.020 |
Why?
|
| Mucopolysaccharidoses | 1 | 1970 | 27 | 0.020 |
Why?
|
| Genes, Dominant | 3 | 1982 | 880 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2012 | 262 | 0.020 |
Why?
|
| Independent Living | 1 | 2015 | 568 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 908 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2012 | 196 | 0.020 |
Why?
|
| California | 1 | 2014 | 1402 | 0.020 |
Why?
|
| Homozygote | 1 | 2015 | 1787 | 0.020 |
Why?
|
| Social Isolation | 1 | 1993 | 365 | 0.020 |
Why?
|
| Prescriptions | 1 | 2013 | 387 | 0.020 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2010 | 34 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9647 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2018 | 2266 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2011 | 329 | 0.020 |
Why?
|
| Guilt | 1 | 1990 | 95 | 0.020 |
Why?
|
| Somatoform Disorders | 1 | 1993 | 423 | 0.020 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2010 | 97 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1991 | 552 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1997 | 881 | 0.020 |
Why?
|
| Brain Concussion | 1 | 1981 | 1320 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3326 | 0.020 |
Why?
|
| Publishing | 1 | 1997 | 833 | 0.020 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 182 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2010 | 195 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2001 | 4561 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 919 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2009 | 52 | 0.020 |
Why?
|
| Individuality | 1 | 2011 | 307 | 0.020 |
Why?
|
| Skin Tests | 1 | 2011 | 613 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1974 | 707 | 0.020 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1989 | 163 | 0.020 |
Why?
|
| Viremia | 1 | 1992 | 736 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1990 | 417 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1992 | 931 | 0.020 |
Why?
|
| Health Services Research | 1 | 1996 | 1836 | 0.020 |
Why?
|
| Tai Ji | 1 | 2012 | 285 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1995 | 1813 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2010 | 363 | 0.020 |
Why?
|
| Acridines | 1 | 1968 | 19 | 0.020 |
Why?
|
| Computer Simulation | 2 | 1993 | 6194 | 0.020 |
Why?
|
| Aggression | 1 | 1993 | 753 | 0.020 |
Why?
|
| Canada | 1 | 2014 | 2065 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2804 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 365 | 0.020 |
Why?
|
| Microglia | 1 | 2017 | 1267 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2015 | 2227 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1996 | 1162 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16690 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 10895 | 0.020 |
Why?
|
| Chlorpromazine | 1 | 1968 | 111 | 0.020 |
Why?
|
| Fathers | 1 | 2011 | 358 | 0.020 |
Why?
|
| Tranquilizing Agents | 1 | 1968 | 59 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 6539 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2850 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 574 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2015 | 986 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1991 | 968 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 322 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2009 | 198 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2010 | 449 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1974 | 3130 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2007 | 61 | 0.020 |
Why?
|
| Occupations | 2 | 1979 | 517 | 0.020 |
Why?
|
| Child Development | 1 | 1999 | 2223 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9735 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 772 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 1462 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 841 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2009 | 63107 | 0.020 |
Why?
|
| Video Games | 1 | 2008 | 184 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2011 | 23404 | 0.020 |
Why?
|
| Down Syndrome | 2 | 1965 | 880 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1903 | 0.020 |
Why?
|
| Cell Division | 1 | 1974 | 4569 | 0.020 |
Why?
|
| Massachusetts | 2 | 2006 | 8662 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2011 | 1420 | 0.020 |
Why?
|
| Body Mass Index | 3 | 2009 | 12721 | 0.020 |
Why?
|
| Linguistics | 1 | 2006 | 98 | 0.020 |
Why?
|
| SEER Program | 2 | 2001 | 1507 | 0.020 |
Why?
|
| Color Perception | 1 | 2006 | 213 | 0.020 |
Why?
|
| Medicare | 2 | 2001 | 6566 | 0.020 |
Why?
|
| Desipramine | 1 | 1985 | 184 | 0.020 |
Why?
|
| Borderline Personality Disorder | 1 | 1992 | 736 | 0.020 |
Why?
|
| Activities of Daily Living | 2 | 1991 | 2419 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1783 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 291 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1977 | 2104 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5077 | 0.020 |
Why?
|
| Paternal Deprivation | 1 | 1983 | 10 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 1989 | 1254 | 0.010 |
Why?
|
| Alcoholic Intoxication | 1 | 1985 | 188 | 0.010 |
Why?
|
| Diet | 1 | 1982 | 7937 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1991 | 3914 | 0.010 |
Why?
|
| New York | 1 | 2006 | 886 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 12746 | 0.010 |
Why?
|
| Gender Identity | 1 | 1989 | 687 | 0.010 |
Why?
|
| Divorce | 1 | 1983 | 79 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2007 | 959 | 0.010 |
Why?
|
| Intention | 1 | 2006 | 342 | 0.010 |
Why?
|
| Prednisolone | 1 | 1984 | 334 | 0.010 |
Why?
|
| Drug Therapy | 1 | 2006 | 497 | 0.010 |
Why?
|
| Convulsive Therapy | 1 | 1982 | 3 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1941 | 0.010 |
Why?
|
| Amoxapine | 1 | 1982 | 5 | 0.010 |
Why?
|
| Dibenzoxazepines | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cystoscopy | 1 | 1983 | 134 | 0.010 |
Why?
|
| Tyramine | 1 | 1982 | 52 | 0.010 |
Why?
|
| Health Surveys | 1 | 2013 | 4036 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1969 | 1124 | 0.010 |
Why?
|
| Bender-Gestalt Test | 1 | 1981 | 3 | 0.010 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2002 | 68 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2566 | 0.010 |
Why?
|
| Dementia | 2 | 1978 | 2518 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2006 | 705 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1992 | 1591 | 0.010 |
Why?
|
| Epididymitis | 1 | 1981 | 37 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2455 | 0.010 |
Why?
|
| Snakes | 1 | 1981 | 30 | 0.010 |
Why?
|
| Theft | 1 | 1961 | 19 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2018 | 7882 | 0.010 |
Why?
|
| Sociology | 1 | 1961 | 21 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2007 | 1169 | 0.010 |
Why?
|
| Artifacts | 1 | 2010 | 1904 | 0.010 |
Why?
|
| Barbiturates | 1 | 1981 | 114 | 0.010 |
Why?
|
| Sleep Deprivation | 1 | 2008 | 832 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 1862 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 109 | 0.010 |
Why?
|
| Enkephalins | 1 | 2001 | 154 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2007 | 2026 | 0.010 |
Why?
|
| Diazepam | 1 | 1981 | 205 | 0.010 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 124 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1677 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1980 | 40 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 1889 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2008 | 1403 | 0.010 |
Why?
|
| Ureter | 1 | 1983 | 375 | 0.010 |
Why?
|
| Amnesia | 1 | 1982 | 248 | 0.010 |
Why?
|
| Infant Behavior | 1 | 2001 | 156 | 0.010 |
Why?
|
| Perphenazine | 1 | 1999 | 34 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 1999 | 11126 | 0.010 |
Why?
|
| Imipramine | 1 | 1979 | 97 | 0.010 |
Why?
|
| Hematoma, Subdural | 1 | 1980 | 126 | 0.010 |
Why?
|
| Pirenzepine | 1 | 1999 | 115 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1961 | 570 | 0.010 |
Why?
|
| Albumins | 1 | 2001 | 568 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2001 | 690 | 0.010 |
Why?
|
| Death | 1 | 1983 | 678 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 4671 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2002 | 875 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1263 | 0.010 |
Why?
|
| Amobarbital | 1 | 1977 | 43 | 0.010 |
Why?
|
| Emigration and Immigration | 1 | 1961 | 402 | 0.010 |
Why?
|
| Consensus | 1 | 2007 | 2960 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8642 | 0.010 |
Why?
|
| Accidents | 1 | 1978 | 164 | 0.010 |
Why?
|
| Cause of Death | 1 | 1988 | 3582 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 1460 | 0.010 |
Why?
|
| Acute Disease | 2 | 1986 | 7147 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1980 | 354 | 0.010 |
Why?
|
| Neoplasms | 3 | 1983 | 21696 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1998 | 367 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2618 | 0.010 |
Why?
|
| Benzothiadiazines | 1 | 1976 | 32 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2001 | 1154 | 0.010 |
Why?
|
| Anura | 1 | 1976 | 86 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1978 | 302 | 0.010 |
Why?
|
| Models, Theoretical | 2 | 1987 | 3589 | 0.010 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1976 | 76 | 0.010 |
Why?
|
| Electroshock | 1 | 1976 | 122 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 1860 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14561 | 0.010 |
Why?
|
| Software | 1 | 2010 | 4441 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 1470 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5856 | 0.010 |
Why?
|
| Insurance Claim Review | 1 | 2000 | 720 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19233 | 0.010 |
Why?
|
| Cheek | 1 | 1975 | 63 | 0.010 |
Why?
|
| Child Behavior | 1 | 2001 | 839 | 0.010 |
Why?
|
| Obstetrical Forceps | 1 | 1974 | 9 | 0.010 |
Why?
|
| Vasopressins | 1 | 1976 | 370 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1980 | 1011 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 1904 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 24252 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1974 | 49 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 6254 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1965 | 4162 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1993 | 75 | 0.010 |
Why?
|
| Tic Disorders | 1 | 1994 | 127 | 0.010 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1993 | 93 | 0.010 |
Why?
|
| Diuretics | 1 | 1976 | 591 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 8551 | 0.010 |
Why?
|
| Hypothalamic Diseases | 1 | 1974 | 135 | 0.010 |
Why?
|
| Outpatients | 1 | 1961 | 1487 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1999 | 956 | 0.010 |
Why?
|
| Resorcinols | 1 | 1972 | 38 | 0.010 |
Why?
|
| Culture Media | 1 | 1974 | 909 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2002 | 2645 | 0.010 |
Why?
|
| School Health Services | 1 | 1975 | 375 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1993 | 279 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1993 | 909 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1992 | 374 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2001 | 3177 | 0.010 |
Why?
|
| Strabismus | 1 | 1974 | 287 | 0.010 |
Why?
|
| Blood Donors | 1 | 1992 | 355 | 0.010 |
Why?
|
| Psychopathology | 1 | 1993 | 409 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4424 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1976 | 1173 | 0.010 |
Why?
|
| Cell Count | 1 | 1974 | 1856 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1972 | 434 | 0.010 |
Why?
|
| Cerebral Palsy | 1 | 1974 | 459 | 0.010 |
Why?
|
| Length of Stay | 1 | 1983 | 6311 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 21833 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1999 | 2684 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1972 | 1101 | 0.000 |
Why?
|
| Cattle | 1 | 1974 | 3922 | 0.000 |
Why?
|
| Sex | 1 | 1967 | 57 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1983 | 3712 | 0.000 |
Why?
|
| Retinitis Pigmentosa | 1 | 1970 | 386 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 11726 | 0.000 |
Why?
|
| HIV Infections | 1 | 1992 | 16715 | 0.000 |
Why?
|
| Dopamine | 1 | 1993 | 1591 | 0.000 |
Why?
|
| Cardiovascular Diseases | 2 | 1983 | 15160 | 0.000 |
Why?
|
| Diphenhydramine | 1 | 1985 | 63 | 0.000 |
Why?
|
| Hepacivirus | 1 | 1992 | 1379 | 0.000 |
Why?
|
| HIV | 1 | 1992 | 1604 | 0.000 |
Why?
|
| Hepatitis, Chronic | 1 | 1984 | 52 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1972 | 2617 | 0.000 |
Why?
|
| Minicomputers | 1 | 1983 | 9 | 0.000 |
Why?
|
| Chlordiazepoxide | 1 | 1963 | 42 | 0.000 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1985 | 288 | 0.000 |
Why?
|
| Visually Impaired Persons | 1 | 1963 | 81 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1981 | 380 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1982 | 383 | 0.000 |
Why?
|
| Lithium Carbonate | 1 | 1981 | 184 | 0.000 |
Why?
|
| Nephrotic Syndrome | 1 | 1984 | 389 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1981 | 376 | 0.000 |
Why?
|
| Cell Line | 1 | 1974 | 16000 | 0.000 |
Why?
|
| Placebos | 1 | 1963 | 1676 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1971 | 6442 | 0.000 |
Why?
|
| Blindness | 1 | 1982 | 615 | 0.000 |
Why?
|
| Hysteria | 1 | 1977 | 22 | 0.000 |
Why?
|
| Creatinine | 1 | 1981 | 1919 | 0.000 |
Why?
|
| Phenothiazines | 1 | 1975 | 63 | 0.000 |
Why?
|
| Psychological Theory | 1 | 1975 | 168 | 0.000 |
Why?
|
| Social Problems | 1 | 1974 | 112 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1981 | 4933 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1978 | 754 | 0.000 |
Why?
|
| Methods | 1 | 1973 | 1129 | 0.000 |
Why?
|
| Writing | 1 | 1974 | 206 | 0.000 |
Why?
|
| Seizures | 1 | 1982 | 2859 | 0.000 |
Why?
|
| Cytodiagnosis | 1 | 1973 | 435 | 0.000 |
Why?
|